Mar 31, 2026
1:40
For every 40 shares held, investors received 1. The price per share adjusted from $0.13 to $0.00.
The split itself did not change the total investment value.
Akari Therapeutics, Plc (AKTX) trades on the NASDAQ Capital Market in the Biotechnology industry.
Akari Therapeutics, Plc company overviewThe latest split shown was on March 31, 2026. It was a 1-for-40 reverse split, so shareholders received 1 share for every 40 they held.
This history records 4 reverse splits between January 3, 2014 and March 31, 2026.